Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay

Francesco Orlando(University of Trento), Crispin T. Hiley(The Francis Crick Institute), Krijn K. Dijkstra(Oncode Institute), Sebastian Brandner(University College London), Scott T. Tagawa(Cornell University), Anuradha Jayaram(Royal London Hospital), Blanca Trujillo(University College London), Sergio A. Quezada(Memorial Sloan Kettering Cancer Center), Simone Zaccaria, Charles Swanton(The Francis Crick Institute), Stephan Beck(London Cancer), Anna Wingate(CRUK Lung Cancer Centre of Excellence), Katey S.S. Enfield(The Francis Crick Institute), Siow Ming Lee(University College London Hospitals NHS Foundation Trust), Michael Sigouros(Cornell University), David R. Pearce, Mark Linch(London Cancer), Sonya Hessey(Royal London Hospital), Jenny Xiang(Cornell University), Mary Falzon, Zoe Rhodes, Robert E. Hynds(The Francis Crick Institute), Chi-wah Lok, Gianmarco Leone(CRUK Lung Cancer Centre of Excellence), Alessandro Romanel(University of Trento), Monica Sivakumar(Cancer Research UK), Mariam Jamal‐Hanjani(CRUK Lung Cancer Centre of Excellence), Dionysis Papadatos-Pastos, Andrew Rowan(Cancer Institute (WIA)), Nicholas McGranahan(CRUK Lung Cancer Centre of Excellence), Tariq Enver(London Cancer), David Moore(University College Hospital), Orsetta Quaini(University of Trento), Sam M. Janes(University College London), Miriam Mitchison(Royal London Hospital), Ariana Huebner(The Francis Crick Institute), Peter Van Loo(Wellcome Sanger Institute), Martin Förster, Daniel Hochhauser(Royal London Hospital), Ron Sinclair, Daniel Wetterskog(CRUK Lung Cancer Centre of Excellence), Ian Proctor, Peter Ellery, Kai‐Keen Shiu(The Francis Crick Institute), Tanya Ahmad(University College London), John Bridgewater(Roche (United States)), Peter J. Parker(King's College London), Chris Abbosh(AstraZeneca (United Kingdom)), Teresa Marafioti(Cancer Research UK)
NAR Cancer
April 8, 2022
Cited by 17


Related Papers